| 產(chǎn)品名稱 | LY 333531 mesylate - Ruboxistaurin |
| 產(chǎn)品貨號 | Axon 1401 CAS [192050-59-2] MF C28H28N4O3.CH4O3SMW 564.65 Purity: 99% Soluble in DMSO Description Orally active protein kinase C β (PKC-β) specific inhibitor; a salt form that is five times more?water-soluble than its hydrochloride salt.The hydrochloride salt of LY 333531 (Axon 2362) is available as well.? KEYWORDS:?LY 333531 mesylate | supplier | PKC-β inhibitor | Ruboxistaurin | LY333531 | LY-333531 | CAS [192050-59-2] | [169939-94-0] | protein kinase | PKC-beta | orally active | ICAM-1 | MCP-1 | diabetes | glutathion | retinopathy |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
LY 333531 mesylate - RuboxistaurinAxon 1401 CAS [192050-59-2] MF C28H28N4O3.CH4O3S
DescriptionOrally active protein kinase C β (PKC-β) specific inhibitor; a salt form that is five times more?water-soluble than its hydrochloride salt. KEYWORDS:?LY 333531 mesylate | supplier | PKC-β inhibitor | Ruboxistaurin | LY333531 | LY-333531 | CAS [192050-59-2] | [169939-94-0] | protein kinase | PKC-beta | orally active | ICAM-1 | MCP-1 | diabetes | glutathion | retinopathy ? List of publications using LY 333531 mesylate (Axon 1401) purchased from Axon Medchem
PKC-β inhibitor
Chemical name13-((Dimethylamino)methyl)-10,11,14,15-tetrahydro-4,9:16,21 -dimetheno-1H,13H-dibenzo(e,k)pyrrolo(3,4-h)(1,4,13) oxadiazacyclohexadecene-1,3(2H)-dione methanesulfonate Parent CAS No.[169939-94-0] |
| 產(chǎn)品資料 |
